# Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

> **NCT02972866** · PHASE3 · WITHDRAWN · sponsor: **Eurofarma Laboratorios S.A.**

## Conditions studied

- Rhinitis, Allergic, Perennial

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT02972866
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-06
- **Primary completion:** 2019-11
- **Final completion:** 2019-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Regulatory strategy
- **Last updated:** 2019-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02972866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02972866, "Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT02972866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*